| 摘要 |
PROBLEM TO BE SOLVED: To provide a compound having thrombopoietin receptor agonism. SOLUTION: The compound having thrombopoietin receptor agonism and represented by general formula (I) (wherein R<SP>1</SP>is a hydrogen atom, a halogen atom, or the like; R<SP>2</SP>, R<SP>3</SP>, and R<SP>4</SP>are each independently a hydrogen atom, a halogen atom, a 1-15C alkyl which may be substituted with a 1-12C alkyloxy or the like at one or more positions, or the like; R<SP>5</SP>is a hydrogen atom or the like; R<SP>6</SP>and R<SP>7</SP>are a halogen atom or the like; R<SP>8</SP>is a 1-3C alkyl or the like; and R<SP>9</SP>is a hydrogen atom or the like), prodrugs thereof, pharmaceutically acceptable salts thereof, and solvates thereof, are provided. COPYRIGHT: (C)2008,JPO&INPIT
|
